Biopharmaceutical company focused on therapies for the eye.
| Year | Firm | Period | Expenses | Doc |
|---|---|---|---|---|
| 2024 | CAPITOL HILL CONSULTING GROUP |
1st Quarter (Jan 1 - Mar 31) Registration |
— |
| Firm | Filings | Expenses |
|---|---|---|
| CAPITOL HILL CONSULTING GROUP | 11 | — |
| Issue | Activities |
|---|---|
| Medicare/Medicaid | 11 |